NO levels in aorta. by Haroldo A. Toque (447341)

Functional consequences of absence of glycosylation in class II strains. by Joseph Gault (427444)

Luciferase reporter expression analysis in A427-derived xenograft tumors following IT injection of rH17d’-Ad5 vectors. by Christopher M. Gentile (6640331)

Morphine decrease co-localization between BrdU-DCX labeled immature neurons, while increase co-localization between BrdU-GFAP labeled glia. by Yue Zhang (30585)

SIRT1, AMPK and PPARγ affect the <i>t</i>10<i>c</i>12 CLA-dependent decrease in the amount of acetylated NF-κB. by Shan Jiang (121292)

P2Y12 deficiency decreases lung metastasis but has no effect on primary tumor growth in the LLC (Lewis lung carcinoma) spontaneous pulmonary metastasis model. by Yanhua Wang (127897)

With efflux pump inhibition, compound O06 and N08 significantly decrease the viability of both exponential and stationary phase <i>K</i>. <i>pneumoniae</i>. by Julie Liao (6111734)

The effect of adjacent WC pairings in triples with a central mismatch. by Hans Binder (128524)

“…It shows that x,y = C and G give rise to largest sensitivities and standard deviation about the mean whereas adjacent x,y = A and T cause smaller sensitivities and variability about the mean.…”

Hypoxia increases NF-κB activity in response to <i>P. aeruginosa</i> but silencing of NF-κB fails to normalize hypoxia induced decreased internalization. by Bettina Schaible (281895)

Presentation 1_Ceftriaxone-associated dysbiosis decreases voriconazole bioavailability by upregulating intestinal P-glycoprotein expression through activation of the Nrf2-mediated... by Xiaokang Wang (733379)

“…The Nrf2 pathway and its related proteins involved in modifying P-glycoprotein (P-gp) expression were clarified by a series of immunoblot analyses.</p>Key findings<p>The diversity and richness of intestinal bacteria, especially the abundance of gram-negative bacteria, were significantly decreased after ceftriaxone treatment. …”

Table 1_Ceftriaxone-associated dysbiosis decreases voriconazole bioavailability by upregulating intestinal P-glycoprotein expression through activation of the Nrf2-mediated signall... by Xiaokang Wang (733379)

“…The Nrf2 pathway and its related proteins involved in modifying P-glycoprotein (P-gp) expression were clarified by a series of immunoblot analyses.</p>Key findings<p>The diversity and richness of intestinal bacteria, especially the abundance of gram-negative bacteria, were significantly decreased after ceftriaxone treatment. …”

Metabolic parameters, netrin-1 expression and vascular functional studies. by Haroldo A. Toque (447341)

Levels of netrin-1, DCC, arginase, NO and ROS in endothelial cells. by Haroldo A. Toque (447341)

<i>Tfrc</i>^{<i>Y20H/Y20H</i>} mice have mild microcytosis and decreased iron levels at homeostasis. by Sarah K. Wideman (17118275)

Inhibition of growth of <i>A</i>. <i>fabrum</i> C58Gm^r by <i>B</i>. <i>velezensis</i> isolate MBY2 in different environments. by Haifa Ben Gharsa (10975000)

Decreased dendritic arbor length and distal branch number of principal neurons from the basolateral amygdala (BLA) of long-term sucrose consuming rats compared to control rats. by Masroor Shariff (2583442)

“…<p><b>A</b> shows a scatter-plot of decreased total dendritic arbor (mean ± SEM) from the BLA in long-term sucrose rats (open squares) compared to controls (open circles) (Unpaired two-tailed Students <i>t</i>-test,*<i>P</i> < 0.05, <i>n</i> = 7; control and <i>n</i> = 7; 12 week sucrose). …”

Molecular signaling in response to high glucose in endothelial cells. by Haroldo A. Toque (447341)

Participant characteristics. by Katharyn L. Flickinger (4759323)

“…However, longer-acting dosing strategies are required to achieve greater levels of metabolic reduction. We explored whether a sublingual loading dose followed by subcutaneous infusion (SQI) of dexmedetomidine with and without surface cooling can decrease metabolic rate for 6 hours. …”

Inhibition of Hh signaling decreases osteopontin and osteopontin-responsive (CD44) positive cells in tumors and peri-tumoral tissues of aged Mdr2^−/− mice. by George M. Philips (206900)

Plasma drug levels by group. by Katharyn L. Flickinger (4759323)

“…However, longer-acting dosing strategies are required to achieve greater levels of metabolic reduction. We explored whether a sublingual loading dose followed by subcutaneous infusion (SQI) of dexmedetomidine with and without surface cooling can decrease metabolic rate for 6 hours. …”